![](/img/cover-not-exists.png)
Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo
Irene Zinonos, Agatha Labrinidis, Michelle Lee, Vasilios Liapis, Shelley Hay, Vladimir Ponomarev, Peter Diamond, David M Findlay, Andrew CW Zannettino, Andreas EvdokiouVolume:
26
Year:
2011
Language:
english
Pages:
14
DOI:
10.1002/jbmr.244
File:
PDF, 590 KB
english, 2011